SK Chemicals Co., Ltd. – Product Pipeline Review

Global Markets Direct’s, ‘SK Chemicals Co., Ltd. – Product Pipeline Review – 2016’, provides an overview of the SK Chemicals Co., Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by SK Chemicals Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of SK Chemicals Co., Ltd.

The report provides overview of SK Chemicals Co., Ltd. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses SK Chemicals Co., Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features SK Chemicals Co., Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate SK Chemicals Co., Ltd.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for SK Chemicals Co., Ltd.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding SK Chemicals Co., Ltd.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

SK Chemicals Co., Ltd. Snapshot 6

SK Chemicals Co., Ltd. Overview 6

Key Information 6

Key Facts 6

SK Chemicals Co., Ltd. - Research and Development Overview 7

Key Therapeutic Areas 7

SK Chemicals Co., Ltd. - Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products - Monotherapy 11

Pipeline Products - Partnered Products 12

Partnered Products/Combination Treatment Modalities 13

SK Chemicals Co., Ltd. - Pipeline Products Glance 14

SK Chemicals Co., Ltd. - Late Stage Pipeline Products 14

Pre-Registration Products/Combination Treatment Modalities 14

Phase III Products/Combination Treatment Modalities 15

SK Chemicals Co., Ltd. - Clinical Stage Pipeline Products 16

Phase I Products/Combination Treatment Modalities 16

SK Chemicals Co., Ltd. - Early Stage Pipeline Products 17

Preclinical Products/Combination Treatment Modalities 17

Discovery Products/Combination Treatment Modalities 18

SK Chemicals Co., Ltd. - Drug Profiles 19

antihemophilic factor (recombinant) 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

NBP-603 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

NBP-606 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

NBP-607 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

THVD-201 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

NBP-608 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

NCE-403 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

SKI-2670 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

NBP-604 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

NBP-611 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

NCE-401 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

NCE-402 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

NCE-405 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

SID-111 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

SID-910 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

SID-920 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

SKI-2162 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

typhoid vaccine 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

Vaccine 2 for Undisclosed Indication 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

pneumonia vaccine 39

Product Description 39

Mechanism of Action 39

R&D Progress 39

SK Chemicals Co., Ltd. - Pipeline Analysis 40

SK Chemicals Co., Ltd. - Pipeline Products by Target 40

SK Chemicals Co., Ltd. - Pipeline Products by Route of Administration 41

SK Chemicals Co., Ltd. - Pipeline Products by Molecule Type 42

SK Chemicals Co., Ltd. - Pipeline Products by Mechanism of Action 43

SK Chemicals Co., Ltd. - Recent Pipeline Updates 44

SK Chemicals Co., Ltd. - Dormant Projects 47

SK Chemicals Co., Ltd. - Locations And Subsidiaries 48

Head Office 48

Other Locations & Subsidiaries 48

Appendix 51

Methodology 51

Coverage 51

Secondary Research 51

Primary Research 51

Expert Panel Validation 51

Contact Us 51

Disclaimer 52

List of Tables

List of Tables

SK Chemicals Co., Ltd., Key Information 6

SK Chemicals Co., Ltd., Key Facts 6

SK Chemicals Co., Ltd. – Pipeline by Indication, 2016 9

SK Chemicals Co., Ltd. – Pipeline by Stage of Development, 2016 10

SK Chemicals Co., Ltd. – Monotherapy Products in Pipeline, 2016 11

SK Chemicals Co., Ltd. – Partnered Products in Pipeline, 2016 12

SK Chemicals Co., Ltd. – Partnered Products/ Combination Treatment Modalities, 2016 13

SK Chemicals Co., Ltd. – Pre-Registration, 2016 14

SK Chemicals Co., Ltd. – Phase III, 2016 15

SK Chemicals Co., Ltd. – Phase I, 2016 16

SK Chemicals Co., Ltd. – Preclinical, 2016 17

SK Chemicals Co., Ltd. – Discovery, 2016 18

SK Chemicals Co., Ltd. – Pipeline by Target, 2016 40

SK Chemicals Co., Ltd. – Pipeline by Route of Administration, 2016 41

SK Chemicals Co., Ltd. – Pipeline by Molecule Type, 2016 42

SK Chemicals Co., Ltd. – Pipeline Products by Mechanism of Action, 2016 43

SK Chemicals Co., Ltd. – Recent Pipeline Updates, 2016 44

SK Chemicals Co., Ltd. – Dormant Developmental Projects,2016 47

SK Chemicals Co., Ltd., Other Locations 48

SK Chemicals Co., Ltd., Subsidiaries 49

List of Figures

List of Figures

SK Chemicals Co., Ltd. – Pipeline by Top 10 Indication, 2016 8

SK Chemicals Co., Ltd. – Pipeline by Stage of Development, 2016 10

SK Chemicals Co., Ltd. – Monotherapy Products in Pipeline, 2016 11

SK Chemicals Co., Ltd. – Partnered Products in Pipeline, 2016 12

SK Chemicals Co., Ltd. – Pipeline by Top 10 Target, 2016 40

SK Chemicals Co., Ltd. – Pipeline by Route of Administration, 2016 41

SK Chemicals Co., Ltd. – Pipeline by Molecule Type, 2016 42

SK Chemicals Co., Ltd. – Pipeline Products by Top 10 Mechanism of Action, 2016 43

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports